Breaking News Instant updates and real-time market news.

MS

Morgan Stanley

$96.02 /

-0.45 (-0.47%)

, JPM

JPMorgan

$151.28 /

-0.16 (-0.11%)

10:52
07/28/21
07/28
10:52
07/28/21
10:52

Morgan Stanley raising pay for junior bankers, Business Insider reports

Morgan Stanley (MS) is the latest bank to raise base pay for junior bankers, following JPMorgan (JPM) and Citi (C), Business Insider's Reed Alexander and Samantha Stokes report. The going rate for first-years is now $100,000, according to the report. Reference Link

MS

Morgan Stanley

$96.02 /

-0.45 (-0.47%)

JPM

JPMorgan

$151.28 /

-0.16 (-0.11%)

C

Citi

$67.77 /

-0.2 (-0.29%)

  • 30

    Jul

  • 03

    Aug

  • 12

    Aug

  • 13

    Oct

  • 14

    Oct

MS Morgan Stanley
$96.02 /

-0.45 (-0.47%)

07/19/21 Citi
Morgan Stanley price target raised to $97 from $88 at Citi
07/16/21 Argus
Morgan Stanley price target raised to $105 from $93 at Argus
07/16/21 BMO Capital
Morgan Stanley price target raised to $103 from $97 at BMO Capital
07/16/21 Piper Sandler
Morgan Stanley price target raised to $100 from $93 at Piper Sandler
JPM JPMorgan
$151.28 /

-0.16 (-0.11%)

07/14/21 Credit Suisse
JPMorgan price target raised to $177 from $170 at Credit Suisse
07/14/21 BMO Capital
JPMorgan price target raised to $141 from $136 at BMO Capital
07/06/21 Keefe Bruyette
JPMorgan assumed with a Market Perform at Keefe Bruyette
06/15/21 BMO Capital
JPMorgan price target trimmed to $139 at BMO Capital on reduced NII view
C Citi
$67.77 /

-0.2 (-0.29%)

07/15/21 Piper Sandler
Citi price target lowered to $91 from $95 at Piper Sandler
07/06/21 Keefe Bruyette
Citi assumed with an Outperform at Keefe Bruyette
06/29/21 Evercore ISI
Evercore says Morgan Stanley the 'standout' on capital plan among DFAST banks
06/08/21 Wells Fargo
Citi price target raised to $95 from $88 at Wells Fargo

TODAY'S FREE FLY STORIES

Initiation
Adobe initiated with an Overweight at Wells Fargo » 06:52
09/20/21
09/20
06:52
09/20/21
06:52
ADBE

Adobe

$655.09 /

-10.26 (-1.54%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

06:26 Today Citi
Adobe shares may be pricing in front office tailwinds, says Citi
09/17/21 Mizuho
Adobe price target raised to $695 from $640 at Mizuho
09/16/21 BMO Capital
Adobe price target raised to $730 from $630 at BMO Capital
09/16/21 Barclays
Adobe price target raised to $740 from $660 at Barclays
ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

Hot Stocks
Independence Contract Drilling signs drilling contract to reactivate 16th rig » 06:50
09/20/21
09/20
06:50
09/20/21
06:50
ICD

Independence Contract Drilling

$2.74 /

-0.02 (-0.72%)

Independence Contract…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
    Hot Stocks
    Bridge Specialty Group announces asset acquisition of Gremesco of New Jersey » 06:48
    09/20/21
    09/20
    06:48
    09/20/21
    06:48
    BRO

    Brown & Brown

    $56.96 /

    -0.495 (-0.86%)

    Brown & Brown and…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BRO Brown & Brown
    $56.96 /

    -0.495 (-0.86%)

    BRO Brown & Brown
    $56.96 /

    -0.495 (-0.86%)

    08/16/21 Wolfe Research
    Brown & Brown initiated with a Peer Perform at Wolfe Research
    07/27/21 Keefe Bruyette
    Keefe Bruyette boosts Brown & Brown target on 'stronger' organic growth
    04/28/21 Deutsche Bank
    Brown & Brown price target raised to $55 from $50 at Deutsche Bank
    04/28/21 RBC Capital
    Brown & Brown price target raised to $53 from $48 at RBC Capital
    BRO Brown & Brown
    $56.96 /

    -0.495 (-0.86%)

    BRO Brown & Brown
    $56.96 /

    -0.495 (-0.86%)

    Hot Stocks
    Pfizer, BioNTech announce results from trial of COVID-19 vaccine in children » 06:47
    09/20/21
    09/20
    06:47
    09/20/21
    06:47
    PFE

    Pfizer

    $43.89 /

    -0.57 (-1.28%)

    , BNTX

    BioNTech

    $358.75 /

    -13.75 (-3.69%)

    Pfizer Inc. (PFE) and…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    BNTX BioNTech
    $358.75 /

    -13.75 (-3.69%)

    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    06:31 Today Citi
    Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
    09/17/21 Evercore ISI
    Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
    09/16/21 Canaccord
    Exact Sciences salesforce expansion a net positive, says Canaccord
    09/16/21 BofA
    Moderna boosters already reflected in 'bullish' consensus, says BofA
    BNTX BioNTech
    $358.75 /

    -13.75 (-3.69%)

    09/17/21 Evercore ISI
    Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
    08/27/21 UBS
    BioNTech price target raised to $300 from $111 at UBS
    08/20/21 Canaccord
    BioNTech price target raised to $450 from $240 at Canaccord
    08/12/21 Wells Fargo
    Wells says Moderna vaccine looks more effective than Pfizer's against Delta
    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    BNTX BioNTech
    $358.75 /

    -13.75 (-3.69%)

    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    BNTX BioNTech
    $358.75 /

    -13.75 (-3.69%)

    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    BNTX BioNTech
    $358.75 /

    -13.75 (-3.69%)

    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    Recommendations
    Molina Healthcare price target raised to $305 from $284 at Mizuho » 06:45
    09/20/21
    09/20
    06:45
    09/20/21
    06:45
    MOH

    Molina Healthcare

    $278.12 /

    +8.09 (+3.00%)

    Mizuho analyst Ann Hynes…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    MOH Molina Healthcare
    $278.12 /

    +8.09 (+3.00%)

    MOH Molina Healthcare
    $278.12 /

    +8.09 (+3.00%)

    09/09/21 Cowen
    Molina Healthcare initiated with an Outperform at Cowen
    09/08/21 Mizuho
    Selloff in managed care sector overdone, says Mizuho
    07/30/21 BMO Capital
    Molina Healthcare price target raised to $315 from $300 at BMO Capital
    07/30/21 Mizuho
    Molina Healthcare price target raised to $284 from $273 at Mizuho
    MOH Molina Healthcare
    $278.12 /

    +8.09 (+3.00%)

    MOH Molina Healthcare
    $278.12 /

    +8.09 (+3.00%)

    Recommendations
    Sale of Voyager more likely than out-licensing, says Benchmark » 06:45
    09/20/21
    09/20
    06:45
    09/20/21
    06:45
    VYGR

    Voyager Therapeutics

    $3.13 /

    +0.09 (+2.96%)

    Over the last two weeks…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    VYGR Voyager Therapeutics
    $3.13 /

    +0.09 (+2.96%)

    VYGR Voyager Therapeutics
    $3.13 /

    +0.09 (+2.96%)

    08/11/21 Benchmark
    Voyager Therapeutics price target lowered to $9 from $20 at Benchmark
    07/09/21 Chardan
    Voyager Therapeutics coverage transferred at Chardan
    05/20/21 Benchmark
    Voyager Therapeutics' 'three-point value' remains despite exits, says Benchmark
    04/26/21 Wedbush
    Wedbush sees FDA clearance of IND for VY-HTT01 as 'clear positive' for Voyager
    VYGR Voyager Therapeutics
    $3.13 /

    +0.09 (+2.96%)

    General news
    FX Action: USD-CAD lifted by over 0.5% in posting a one-month high » 06:45
    09/20/21
    09/20
    06:45
    09/20/21
    06:45
    $ECON

    Economic Data

    /

    +

    FX Action: USD-CAD lifted…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    $ECON Economic Data
    /

    +

    $ECON Economic Data
    /

    +

    Hot Stocks
    Aerie appoints Erik Pacyniak as director, toxicology, drug disposition » 06:39
    09/20/21
    09/20
    06:39
    09/20/21
    06:39
    AERI

    Aerie Pharmaceuticals

    $12.84 /

    +0.495 (+4.01%)

    Aerie Pharmaceuticals…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    AERI Aerie Pharmaceuticals
    $12.84 /

    +0.495 (+4.01%)

    AERI Aerie Pharmaceuticals
    $12.84 /

    +0.495 (+4.01%)

    11/09/20 H.C. Wainwright
    Aerie Pharmaceuticals price target lowered to $29 from $31 at H.C. Wainwright
    10/28/20 H.C. Wainwright
    Aerie Pharmaceuticals $50M upfront should reduce overhang, says H.C. Wainwright
    10/19/20 BofA
    Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
    10/19/20 BofA
    Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
    AERI Aerie Pharmaceuticals
    $12.84 /

    +0.495 (+4.01%)

    AERI Aerie Pharmaceuticals
    $12.84 /

    +0.495 (+4.01%)

    Initiation
    Li-Cycle initiated with an Outperform at Wedbush » 06:39
    09/20/21
    09/20
    06:39
    09/20/21
    06:39
    LICY

    Li-Cycle

    $8.77 /

    +0.09 (+1.04%)

    Wedbush analyst Daniel…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    LICY Li-Cycle
    $8.77 /

    +0.09 (+1.04%)

    LICY Li-Cycle
    $8.77 /

    +0.09 (+1.04%)

    09/13/21 Morgan Stanley
    Li-Cycle initiated with an Overweight at Morgan Stanley
    09/09/21 BMO Capital
    Li-Cycle initiated with an Outperform at BMO Capital
    08/23/21 Baird
    Baird starts Li-Cycle at Neutral, sees 'discounted multiple' as warranted
    08/23/21 Baird
    Li-Cycle initiated with a Neutral at Baird
    LICY Li-Cycle
    $8.77 /

    +0.09 (+1.04%)

    LICY Li-Cycle
    $8.77 /

    +0.09 (+1.04%)

    LICY Li-Cycle
    $8.77 /

    +0.09 (+1.04%)

    Hot Stocks
    ChromaDex announces preclincal research findings from CERP » 06:38
    09/20/21
    09/20
    06:38
    09/20/21
    06:38
    CDXC

    ChromaDex

    $6.75 /

    +0.44 (+6.97%)

    ChromaDex announced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    CDXC ChromaDex
    $6.75 /

    +0.44 (+6.97%)

    CDXC ChromaDex
    $6.75 /

    +0.44 (+6.97%)

    08/04/21 H.C. Wainwright
    ChromaDex price target raised to $12 from $11 at H.C. Wainwright
    06/07/21 H.C. Wainwright
    ChromaDex sales momentum should accelerate, says H.C. Wainwright
    03/16/21 H.C. Wainwright
    ChromaDex price target raised to $16 from $7 at H.C. Wainwright
    03/08/21 B. Riley Securities
    ChromaDex price target raised to $18 from $7 at B. Riley Securities
    CDXC ChromaDex
    $6.75 /

    +0.44 (+6.97%)

    CDXC ChromaDex
    $6.75 /

    +0.44 (+6.97%)

    CDXC ChromaDex
    $6.75 /

    +0.44 (+6.97%)

    Hot Stocks
    Sanofi reports Libtayo Phase 3 trial met primary, key secondary endpoints » 06:38
    09/20/21
    09/20
    06:38
    09/20/21
    06:38
    SNY

    Sanofi

    $48.35 /

    +0.14 (+0.29%)

    , REGN

    Regeneron

    $651.38 /

    -2.3 (-0.35%)

    Phase 3 results for…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    SNY Sanofi
    $48.35 /

    +0.14 (+0.29%)

    REGN Regeneron
    $651.38 /

    -2.3 (-0.35%)

    SNY Sanofi
    $48.35 /

    +0.14 (+0.29%)

    06:31 Today Citi
    Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
    09/14/21 Mizuho
    Kadmon downgraded to Neutral from Buy at Mizuho
    09/10/21 UBS
    Kadmon downgraded to Neutral from Buy at UBS
    09/09/21 RBC Capital
    Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
    REGN Regeneron
    $651.38 /

    -2.3 (-0.35%)

    09/15/21 Cantor Fitzgerald
    Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
    09/15/21 H.C. Wainwright
    Regeneron price target raised to $831 from $787 at H.C. Wainwright
    09/15/21 Piper Sandler
    Regeneron price target raised to $690 from $675 at Piper Sandler
    09/09/21
    Fly Intel: Top five analyst initiations
    SNY Sanofi
    $48.35 /

    +0.14 (+0.29%)

    REGN Regeneron
    $651.38 /

    -2.3 (-0.35%)

    SNY Sanofi
    $48.35 /

    +0.14 (+0.29%)

    REGN Regeneron
    $651.38 /

    -2.3 (-0.35%)

    SNY Sanofi
    $48.35 /

    +0.14 (+0.29%)

    REGN Regeneron
    $651.38 /

    -2.3 (-0.35%)

    REGN Regeneron
    $651.38 /

    -2.3 (-0.35%)

    Hot Stocks
    Synlogic announces data from studies evaluating SYNB1618, SYNB1934 » 06:38
    09/20/21
    09/20
    06:38
    09/20/21
    06:38
    SYBX

    Synlogic

    $3.25 /

    +0.06 (+1.88%)

    Synlogic announced data…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    SYBX Synlogic
    $3.25 /

    +0.06 (+1.88%)

    SYBX Synlogic
    $3.25 /

    +0.06 (+1.88%)

    07/09/21 Chardan
    Synlogic assumed with a Buy at Chardan
    06/28/21 H.C. Wainwright
    Synlogic price target lowered to $9 from $13 at H.C. Wainwright
    03/25/21 SVB Leerink
    Synlogic price target raised to $15 from $10 at SVB Leerink
    03/18/21 JonesTrading
    Synlogic initiated with a Buy at JonesTrading
    SYBX Synlogic
    $3.25 /

    +0.06 (+1.88%)

    • 16
      Apr
    SYBX Synlogic
    $3.25 /

    +0.06 (+1.88%)

    Recommendations
    Personalis Veterans Affairs contract smaller than expected, says Citi » 06:37
    09/20/21
    09/20
    06:37
    09/20/21
    06:37
    PSNL

    Personalis

    $22.34 /

    +1.25 (+5.93%)

    Citi analyst Patrick…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    PSNL Personalis
    $22.34 /

    +1.25 (+5.93%)

    PSNL Personalis
    $22.34 /

    +1.25 (+5.93%)

    08/05/21 Citi
    Personalis price target lowered to $30 from $37 at Citi
    05/13/21 Truist
    Personalis price target lowered to $29 from $37 at Truist
    05/06/21 Oppenheimer
    Personalis upgraded to Outperform at Oppenheimer on multi-year growth cycle
    05/06/21 Oppenheimer
    Personalis upgraded to Outperform from Perform at Oppenheimer
    PSNL Personalis
    $22.34 /

    +1.25 (+5.93%)

    • 27
      Jan
    PSNL Personalis
    $22.34 /

    +1.25 (+5.93%)

    Hot Stocks
    Adagio Therapeutics expands patient population in EVADE Phase 2/3 trial » 06:36
    09/20/21
    09/20
    06:36
    09/20/21
    06:36
    ADGI

    Adagio Therapeutics

    $51.51 /

    -4.46 (-7.97%)

    The independent data…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    ADGI Adagio Therapeutics
    $51.51 /

    -4.46 (-7.97%)

    08/31/21
    Fly Intel: Top five analyst initiations
    08/31/21 Guggenheim
    Adagio Therapeutics initiated with a Buy at Guggenheim
    08/31/21 Stifel
    Adagio Therapeutics initiated with a Buy at Stifel
    08/31/21 Jefferies
    Adagio Therapeutics initiated with a Buy at Jefferies
    ADGI Adagio Therapeutics
    $51.51 /

    -4.46 (-7.97%)

    • 06
      Aug
    ADGI Adagio Therapeutics
    $51.51 /

    -4.46 (-7.97%)

    General news
    Oil prices have dropped back » 06:35
    09/20/21
    09/20
    06:35
    09/20/21
    06:35
    $ECON

    Economic Data

    /

    +

    Oil prices have dropped…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    $ECON Economic Data
    /

    +

    $ECON Economic Data
    /

    +

    Earnings
    Adagio Therapeutics reports Q2 EPS (18c) vs. (66c) last year » 06:34
    09/20/21
    09/20
    06:34
    09/20/21
    06:34
    ADGI

    Adagio Therapeutics

    $51.51 /

    -4.46 (-7.97%)

    "Across the globe,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    ADGI Adagio Therapeutics
    $51.51 /

    -4.46 (-7.97%)

    08/31/21
    Fly Intel: Top five analyst initiations
    08/31/21 Guggenheim
    Adagio Therapeutics initiated with a Buy at Guggenheim
    08/31/21 Stifel
    Adagio Therapeutics initiated with a Buy at Stifel
    08/31/21 Jefferies
    Adagio Therapeutics initiated with a Buy at Jefferies
    • 06
      Aug
    ADGI Adagio Therapeutics
    $51.51 /

    -4.46 (-7.97%)

    Hot Stocks
    Brown & Brown announces asset acquisition of AGIS Network » 06:33
    09/20/21
    09/20
    06:33
    09/20/21
    06:33
    BRO

    Brown & Brown

    $56.96 /

    -0.495 (-0.86%)

    Brown & Brown and…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BRO Brown & Brown
    $56.96 /

    -0.495 (-0.86%)

    BRO Brown & Brown
    $56.96 /

    -0.495 (-0.86%)

    08/16/21 Wolfe Research
    Brown & Brown initiated with a Peer Perform at Wolfe Research
    07/27/21 Keefe Bruyette
    Keefe Bruyette boosts Brown & Brown target on 'stronger' organic growth
    04/28/21 Deutsche Bank
    Brown & Brown price target raised to $55 from $50 at Deutsche Bank
    04/28/21 RBC Capital
    Brown & Brown price target raised to $53 from $48 at RBC Capital
    BRO Brown & Brown
    $56.96 /

    -0.495 (-0.86%)

    BRO Brown & Brown
    $56.96 /

    -0.495 (-0.86%)

    Hot Stocks
    Brooks Automation to sell semiconductor solutions group business for $3B » 06:32
    09/20/21
    09/20
    06:32
    09/20/21
    06:32
    BRKS

    Brooks Automation

    $94.21 /

    +1.46 (+1.57%)

    Brooks Automation…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    BRKS Brooks Automation
    $94.21 /

    +1.46 (+1.57%)

    BRKS Brooks Automation
    $94.21 /

    +1.46 (+1.57%)

    09/07/21 KeyBanc
    Brooks Automation price target raised to $146 from $115 at KeyBanc
    05/11/21 Needham
    Brooks Automation price target raised to $130 from $110 at Needham
    05/11/21 Credit Suisse
    Brooks Automation price target raised to $85 from $70 at Credit Suisse
    05/11/21 B. Riley
    Brooks Automation price target raised to $130 from $125 at B. Riley
    BRKS Brooks Automation
    $94.21 /

    +1.46 (+1.57%)

    BRKS Brooks Automation
    $94.21 /

    +1.46 (+1.57%)

    BRKS Brooks Automation
    $94.21 /

    +1.46 (+1.57%)

    Hot Stocks
    Thomas H. Lee to acquire automation business from Brooks Automation for $3B » 06:32
    09/20/21
    09/20
    06:32
    09/20/21
    06:32
    BRKS

    Brooks Automation

    $94.21 /

    +1.46 (+1.57%)

    Thomas H. Lee Partners…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BRKS Brooks Automation
    $94.21 /

    +1.46 (+1.57%)

    BRKS Brooks Automation
    $94.21 /

    +1.46 (+1.57%)

    09/07/21 KeyBanc
    Brooks Automation price target raised to $146 from $115 at KeyBanc
    05/11/21 Needham
    Brooks Automation price target raised to $130 from $110 at Needham
    05/11/21 Credit Suisse
    Brooks Automation price target raised to $85 from $70 at Credit Suisse
    05/11/21 B. Riley
    Brooks Automation price target raised to $130 from $125 at B. Riley
    BRKS Brooks Automation
    $94.21 /

    +1.46 (+1.57%)

    BRKS Brooks Automation
    $94.21 /

    +1.46 (+1.57%)

    BRKS Brooks Automation
    $94.21 /

    +1.46 (+1.57%)

    Recommendations
    Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote » 06:31
    09/20/21
    09/20
    06:31
    09/20/21
    06:31
    PFE

    Pfizer

    $43.89 /

    -0.57 (-1.28%)

    , AZN

    AstraZeneca

    $55.56 /

    -1.04 (-1.84%)

    , ABBV

    AbbVie

    $107.75 /

    -0.33 (-0.31%)

    , BMY

    Bristol-Myers

    $61.32 /

    +0.1 (+0.16%)

    , RHHBY

    Roche

    $46.07 /

    -0.75 (-1.60%)

    , NVO

    Novo Nordisk

    $101.45 /

    -0.945 (-0.92%)

    , SNY

    Sanofi

    $48.35 /

    +0.14 (+0.29%)

    Despite Friday's…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    AZN AstraZeneca
    $55.56 /

    -1.04 (-1.84%)

    ABBV AbbVie
    $107.75 /

    -0.33 (-0.31%)

    BMY Bristol-Myers
    $61.32 /

    +0.1 (+0.16%)

    RHHBY Roche
    $46.07 /

    -0.75 (-1.60%)

    NVO Novo Nordisk
    $101.45 /

    -0.945 (-0.92%)

    SNY Sanofi
    $48.35 /

    +0.14 (+0.29%)

    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    09/17/21 Evercore ISI
    Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
    09/16/21 Canaccord
    Exact Sciences salesforce expansion a net positive, says Canaccord
    09/16/21 BofA
    Moderna boosters already reflected in 'bullish' consensus, says BofA
    09/15/21 Raymond James
    Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
    AZN AstraZeneca
    $55.56 /

    -1.04 (-1.84%)

    09/17/21 Evercore ISI
    Innate Pharma price target raised to $10 from $6 at Evercore ISI
    09/17/21 Morgan Stanley
    AstraZeneca price target raised to 10,000 GBp from 9,800 GBp at Morgan Stanley
    09/09/21 RBC Capital
    Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
    08/12/21 JPMorgan
    AstraZeneca resumed with an Overweight at JPMorgan
    ABBV AbbVie
    $107.75 /

    -0.33 (-0.31%)

    09/14/21 Barclays
    Regenxbio price target raised to $82 from $79 at Barclays
    09/13/21 Chardan
    Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
    09/08/21 JPMorgan
    AbbVie offers 'best risk/reward story in the group,' says JPMorgan
    09/07/21 Morgan Stanley
    Morgan Stanley cuts Vertex Pharmaceuticals to Underweight amid AbbVie overhang
    BMY Bristol-Myers
    $61.32 /

    +0.1 (+0.16%)

    09/09/21 RBC Capital
    Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
    07/27/21 Mizuho
    Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
    07/26/21 Truist
    Bristol-Myers assumed with a Buy at Truist
    07/26/21 Truist
    Bristol-Myers assumed with a Buy at Truist
    RHHBY Roche
    $46.07 /

    -0.75 (-1.60%)

    09/09/21 RBC Capital
    Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
    09/07/21 UBS
    Roche price target raised to CHF 350 from CHF 345 at UBS
    08/02/21 JPMorgan
    Roche price target raised to CHF 360 from CHF 310 at JPMorgan
    07/27/21 Societe Generale
    Roche price target raised to CHF 353 from CHF 340 at Societe Generale
    NVO Novo Nordisk
    $101.45 /

    -0.945 (-0.92%)

    09/03/21 Berenberg
    Novo Nordisk price target raised to DKK 530 from DKK 430 at Berenberg
    08/23/21 Credit Suisse
    Novo Nordisk price target raised to DKK 625 from DKK 470 at Credit Suisse
    08/23/21 Citi
    Novo Nordisk price target raised to DKK 780 from DKK 510 at Citi
    08/17/21 UBS
    Novo Nordisk price target raised to DKK 630 from DKK 447 at UBS
    SNY Sanofi
    $48.35 /

    +0.14 (+0.29%)

    09/14/21 Mizuho
    Kadmon downgraded to Neutral from Buy at Mizuho
    09/10/21 UBS
    Kadmon downgraded to Neutral from Buy at UBS
    09/09/21 RBC Capital
    Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
    09/09/21 Benchmark
    Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    AZN AstraZeneca
    $55.56 /

    -1.04 (-1.84%)

    ABBV AbbVie
    $107.75 /

    -0.33 (-0.31%)

    BMY Bristol-Myers
    $61.32 /

    +0.1 (+0.16%)

    RHHBY Roche
    $46.07 /

    -0.75 (-1.60%)

    NVO Novo Nordisk
    $101.45 /

    -0.945 (-0.92%)

    SNY Sanofi
    $48.35 /

    +0.14 (+0.29%)

    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    AZN AstraZeneca
    $55.56 /

    -1.04 (-1.84%)

    ABBV AbbVie
    $107.75 /

    -0.33 (-0.31%)

    BMY Bristol-Myers
    $61.32 /

    +0.1 (+0.16%)

    RHHBY Roche
    $46.07 /

    -0.75 (-1.60%)

    SNY Sanofi
    $48.35 /

    +0.14 (+0.29%)

    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    AZN AstraZeneca
    $55.56 /

    -1.04 (-1.84%)

    ABBV AbbVie
    $107.75 /

    -0.33 (-0.31%)

    BMY Bristol-Myers
    $61.32 /

    +0.1 (+0.16%)

    RHHBY Roche
    $46.07 /

    -0.75 (-1.60%)

    NVO Novo Nordisk
    $101.45 /

    -0.945 (-0.92%)

    SNY Sanofi
    $48.35 /

    +0.14 (+0.29%)

    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    AZN AstraZeneca
    $55.56 /

    -1.04 (-1.84%)

    ABBV AbbVie
    $107.75 /

    -0.33 (-0.31%)

    BMY Bristol-Myers
    $61.32 /

    +0.1 (+0.16%)

    General news
    FOMC forecasts » 06:30
    09/20/21
    09/20
    06:30
    09/20/21
    06:30
    $ECON

    Economic Data

    /

    +

    FOMC forecasts to be…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    $ECON Economic Data
    /

    +

    $ECON Economic Data
    /

    +

    Hot Stocks
    Eros STX Global bondholders approve amendment to extend maturity date » 06:29
    09/20/21
    09/20
    06:29
    09/20/21
    06:29
    ESGC

    Eros STX Global

    /

    +

    Eros STX Global announces…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    ESGC Eros STX Global
    /

    +

    ESGC Eros STX Global
    /

    +

    ESGC Eros STX Global
    /

    +

    Recommendations
    NRG Energy removed from US 1 List at BofA  06:27
    09/20/21
    09/20
    06:27
    09/20/21
    06:27
    NRG

    NRG Energy

    $42.07 /

    -0.93 (-2.16%)

     
    ShowHide Related Items >><<
    NRG NRG Energy
    $42.07 /

    -0.93 (-2.16%)

    NRG NRG Energy
    $42.07 /

    -0.93 (-2.16%)

    06/27/21 Goldman Sachs
    NRG Energy upgraded to Conviction Buy from Buy at Goldman Sachs
    06/21/21 Seaport Global
    NRG Energy price target raised to $47 from $42 at Seaport Global
    03/18/21
    Fly Intel: Top five analyst downgrades
    03/18/21 Morgan Stanley
    NRG Energy price target lowered to $51 from $59 at Morgan Stanley
    NRG NRG Energy
    $42.07 /

    -0.93 (-2.16%)

    NRG NRG Energy
    $42.07 /

    -0.93 (-2.16%)

    Hot Stocks
    SmileDirectClub up 15% in pre-market trading at $7.71 per share » 06:27
    09/20/21
    09/20
    06:27
    09/20/21
    06:27
    SDC

    SmileDirectClub

    $6.70 /

    +0.705 (+11.76%)

    Shares of SmileDirectClub…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    SDC SmileDirectClub
    $6.70 /

    +0.705 (+11.76%)

    SDC SmileDirectClub
    $6.70 /

    +0.705 (+11.76%)

    08/13/21
    Fly Intel: Top five analyst downgrades
    08/13/21 Wolfe Research
    SmileDirectClub downgraded to Peer Perform from Outperform at Wolfe Research
    08/10/21
    Fly Intel: Top five analyst downgrades
    08/10/21 Loop Capital
    SmileDirectClub price target lowered to $6 from $9 at Loop Capital
    SDC SmileDirectClub
    $6.70 /

    +0.705 (+11.76%)

    • 24
      Nov
    • 19
      Nov
    SDC SmileDirectClub
    $6.70 /

    +0.705 (+11.76%)

    SDC SmileDirectClub
    $6.70 /

    +0.705 (+11.76%)

    SDC SmileDirectClub
    $6.70 /

    +0.705 (+11.76%)

    Recommendations
    Adobe shares may be pricing in front office tailwinds, says Citi » 06:26
    09/20/21
    09/20
    06:26
    09/20/21
    06:26
    ADBE

    Adobe

    $655.09 /

    -10.26 (-1.54%)

    Citi analyst Tyler Radke…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ADBE Adobe
    $655.09 /

    -10.26 (-1.54%)

    ADBE Adobe
    $655.09 /

    -10.26 (-1.54%)

    09/17/21 Mizuho
    Adobe price target raised to $695 from $640 at Mizuho
    09/16/21 BMO Capital
    Adobe price target raised to $730 from $630 at BMO Capital
    09/16/21 Barclays
    Adobe price target raised to $740 from $660 at Barclays
    09/15/21 Morgan Stanley
    Adobe price target raised to $736 from $610 at Morgan Stanley
    ADBE Adobe
    $655.09 /

    -10.26 (-1.54%)

    ADBE Adobe
    $655.09 /

    -10.26 (-1.54%)

    ADBE Adobe
    $655.09 /

    -10.26 (-1.54%)

    ADBE Adobe
    $655.09 /

    -10.26 (-1.54%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.